The company says this marks the world’s first robotic-assisted HoLEP procedure. Dr. Cristián Trucco of Universidad Católica performed the case via a tablet interface to kick off the ASTRA clinical trial. Trucco and Dr. Rodrigo Ledezma intend to continue enrolling patients in the coming months.

Andromeda designed its endoscopic robotic platform to integrate seamlessly with existing surgical tools. It aims to provide surgeons with enhanced control and efficiency during transurethral procedures.

Founded in 2023, Andromeda says it brought its platform from initial concept to clinical use in just 18 months. It aims to enable urologists to perform HoLEP at an expert level to treat benign prostatic hyperplasia (BPH or enlarged prostate).